Kaufman Et Broad (0F07)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 19.03 |
|---|---|
| 52-week range | 18.44 – 32.95 |
| Return, 1 month / 3 months | −9.2% / −26.2% |
| Return, 1 year / 3 years | −29.6% / −6.7% |
| Trend | Below its 200-day average |
| RSI (14) | 36 |
| Volatility (1 year) | 23.3% |
| Worst drawdown (1 year) | -38.6% |
| Average daily value traded | 0.07M EUR |
| Dividend yield | 11.6% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Kaufman Et Broad is a French property developer and housebuilder based in France. It designs and builds new homes, apartments and residential developments, and it also offers related services to homebuyers, including assistance with customising and financing their purchases. Its customers are mainly individual buyers and households looking for new-build housing, along with public bodies and investors involved in residential projects. The company operates across France through regional branches that handle land acquisition, construction and sales.
On this site Kaufman Et Broad appears as a stock on the London Exchange (UK), code 0F07, with prices in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Kaufman Et Broad (0F07) trades on the London Exchange in UK. It last closed at EUR 19.03 on 23 October 2026.
Its price-based Market X-Ray is 32 out of 100 (a weak price profile), ranking 3,011 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 29.6% and over the last three months it fell 26.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 14 · Weak | Below its long-term averages and far from its highs. | |
| Above 200-day average | -24.5% | ||
| From 52-week high | -42.0% | ||
| Momentum | 13 · Weak | Lagging most stocks on this exchange. | |
| 3-month return | -26.2% | ||
| 6-month return | -27.4% | ||
| 12-month return, skipping the last month | -22.5% | ||
| Stability (higher is calmer) | 56 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 23.3% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.6% | ||
| Liquidity | 27 · Weak | Thinly traded: prices can jump and exits can be hard. | |
| Average daily value traded | 0.07M EUR | ||
| Zero-volume days | 10.0% | ||
| Income | 69 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 11.6% | ||
| Years with dividends | 5 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
- Trend: Below its long-term averages and far from its highs.
- Momentum: Lagging most stocks on this exchange.
- Liquidity: Thinly traded: prices can jump and exits can be hard.
Returns
| 1 week | −1.7% |
|---|---|
| 1 month | −9.2% |
| 3 months | −26.2% |
| 6 months | −27.4% |
| 1 year | −29.6% |
| 3 years | −6.7% |
| 5 years | −18.4% |
Signals
| 50-day / 200-day average | 21.52 / 25.19 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | Yes |
| Average daily range (ATR) | 4.16 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 11 May 2026 | EUR 2.2000 |
| 9 May 2025 | EUR 2.2000 |
| 9 May 2024 | EUR 2.4000 |
| 9 May 2023 | EUR 2.4000 |
| 1 Jun 2022 | EUR 1.9500 |
| 2 Jun 2021 | EUR 1.8500 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.